List of insiders holdings for MISONIX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | 1315 Capital Management LLC 1315 Capital L.P. 10% Owner |
2021-02-05 16:49:27 | 0 1,695,969 |
1,695,969 | Form 4 |
2 | SVLSF VI LLC SV Life Sciences Fund VI L.P. SV Life Sciences Fund VI (GP) L.P. SV Life Sciences Fund VI Strategic Partners L.P. 10% Owner |
2021-02-16 16:01:08 | 1,694,017 0 |
1,694,017 | Form 13G |
3 | MCMANUS MICHAEL A JR President and CEO |
2016-07-01 13:28:57 | 426,017 0 |
426,017 | Form 4 |
4 | GELMAN GARY 10% Owner |
2010-03-19 09:13:07 | 348,672 0 |
348,672 | Form 13D |
5 | ZAREMBA RICHARD A Sr. VP - Finance |
2017-06-06 10:59:18 | 138,523 0 |
138,523 | Form 4 |
6 | ALLIGER HOWARD Director Emeritus |
2015-06-17 06:00:49 | 70,400 0 |
70,400 | Form 4 |
7 | Napoli Frank VP, Operations |
2014-06-12 10:30:02 | 41,500 0 |
41,500 | Form 4 |
8 | Manna Ronald VP, Quality & Reg. Aff. |
2015-02-24 15:40:08 | 36,475 0 |
36,475 | Form 4 |
9 | Ryan Michael C SVP, Medical Division |
2012-09-13 13:27:24 | 35,000 0 |
35,000 | Form 4 |
10 | Klugewicz Sharon W Chief Operating Officer |
2021-07-02 16:30:37 | 15,000 0 |
15,000 | Form 4 |
11 | Waggoner Jonathan Jay SVP, Wound Sales |
2021-07-02 16:31:00 | 15,000 0 |
15,000 | Form 4 |
12 | MINETTI T GUY Director |
2016-02-08 14:30:59 | 15,000 0 |
15,000 | Form 4 |
13 | GILDEA JOHN Director |
2017-08-18 16:06:05 | 15,000 0 |
15,000 | Form 4 |
14 | McBrayer Patrick A Director |
2018-11-16 10:51:14 | 15,000 0 |
15,000 | Form 4 |
15 | Miner Charles Director |
2018-11-16 10:46:18 | 15,000 0 |
15,000 | Form 4 |
16 | Berger Bernhard VP-Industrial/Scientific Prod. |
2005-03-04 10:12:37 | 13,334 0 |
13,334 | Form 4 |
17 | VOIC DAN VP, R&D and Engineering |
2018-07-26 16:06:00 | 12,000 0 |
12,000 | Form 4 |
18 | Salerno John Joseph VP, Quality & Regulatory |
2018-07-26 16:05:21 | 10,000 0 |
10,000 | Form 4 |
19 | Constantine W Paul SVP, Sales & New Prod. |
2006-10-24 10:31:46 | 10,000 0 |
10,000 | Form 4 |
20 | Staley Allan Richard President |
2020-07-02 13:36:23 | 8,465 0 |
8,465 | Form 4 |
21 | Consilvio Michael L VP-Marketing |
2016-12-08 19:51:37 | 8,000 0 |
8,000 | Form 4 |
22 | ONEILL THOMAS F Director |
2015-02-26 08:33:40 | 6,300 0 |
6,300 | Form 4 |
23 | Brennan Joseph J VP, Operations |
2019-02-12 16:30:25 | 5,292 0 |
5,292 | Form 4 |
24 | Staub Linwood A. Sr. VP Wound |
2020-07-02 13:40:21 | 4,998 0 |
4,998 | Form 4 |
25 | Coviello Kenneth V.P - Medical Devices |
2005-09-28 15:08:53 | 4,000 0 |
4,000 | Form 4 |
26 | Watanabe Gwendolyn A Director |
2020-07-02 13:37:24 | 3,060 0 |
3,060 | Form 4 |
27 | Wright Christopher H VP - US Sales |
2018-11-29 12:42:04 | 0 2,000 |
2,000 | Form 4 |
28 | Beyer Pat Director |
2021-12-08 16:42:27 | 0 0 |
0 | Form 4 |
29 | Dwyer Joseph P Chief Financial Officer |
2021-12-08 16:45:12 | 0 0 |
0 | Form 4 |
30 | LAVIOLETTE PAUL A Director |
2021-12-08 16:47:41 | 0 0 |
0 | Form 4 |
31 | Ludecker Robert S SVP, Global Sales - Marketing |
2021-12-08 16:50:53 | 0 0 |
0 | Form 4 |
32 | PATTON THOMAS M Director |
2021-12-08 16:53:29 | 0 0 |
0 | Form 4 |
33 | Vizirgianakis Stavros G. President and CEO |
2021-12-08 16:56:38 | 0 0 |
0 | Form 4 |
34 | Koby Michael Director |
2021-12-08 17:01:08 | 0 0 |
0 | Form 4 |